SCHEDULE 13G/A: Brown Capital Management Reports Zero Beneficial Ownership in Inogen, Inc.

Brown Capital Management, LLC has filed an amended Schedule 13G indicating it no longer holds beneficial ownership in Inogen, Inc., reporting 0% of the common stock.

Summary

• Brown Capital Management, LLC filed an Amendment No. 14 to Schedule 13G regarding its beneficial ownership of Inogen, Inc. common stock.
• As of March 31, 2025, Brown Capital Management, LLC reports 0% beneficial ownership of Inogen, Inc.'s common stock.
• This includes 0 shares with sole voting power, shared voting power, sole dispositive power, and shared dispositive power.
• The filing certifies that the securities were acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Inogen, Inc.

Sentiment

Score: 3

Explanation: The complete divestment of shares by an institutional investor, while a routine portfolio adjustment for the investor, can be interpreted negatively by the market regarding the issuer's prospects.

Negatives

• Brown Capital Management, LLC, a notable institutional investor, has reduced its beneficial ownership in Inogen, Inc. to 0%, which could be interpreted negatively by the market as a divestment of its entire previously reported stake.

Risks

• Potential negative market perception for Inogen, Inc. due to a significant institutional investor divesting its entire reported stake, which might signal a lack of confidence or a change in investment strategy regarding the company.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding Inogen, Inc.'s future operations or financial performance. It only pertains to the reporting person's past ownership.

Management Comments

• "The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."

Industry Context

This filing reflects a change in an institutional investor's position in a medical technology company. Such divestments by asset managers are common and can be driven by various factors, including portfolio rebalancing, changes in investment strategy, or a revised outlook on the company or sector. It does not inherently indicate a broader industry trend without further context.

Stakeholder Impact

• Shareholders: Potential negative sentiment due to a significant institutional investor divesting its entire reported stake, which could lead to downward pressure on the stock price.

Key Dates

Recommendation

Keywords

Inogen Inc., Brown Capital Management, Schedule 13G, beneficial ownership, common stock, institutional investor, divestment, SEC filing